2026-05-13T16:52:32-05:00 2025-12-31 330783700 PDM LLP 3460 TORRANCE BLVD STE 200 TORRANCE CA 90503 990 2025-01-01 264712664 OPEN MEDICINE FOUNDATION OPEN 6502428669 5737 KANAN ROAD 544 AGOURA HILLS CA 91301 KIMBERLY HICKS COO/CFO/TREASURER 6502428669 2026-05-13 1 ANTHONY P BOZANIC CPA P01314417 3105404118 2025 2025-03-06 01:10:19Z X KIMBERLY HICKS 5737 KANAN ROAD 544 AGOURA HILLS CA 91301 5487605 0 X OMF.NGO X 2009 CA FUNDING COLLABORTIVE MEDICAL RESEARCH AND EDUCATION FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES. 7 5 7 7 0 0 3790096 5136428 0 0 271551 230517 207937 120660 4269584 5487605 3429458 2525383 0 0 1471186 1541969 0 0 532775 476574 506293 5377218 4573645 -1107634 913960 7311452 8641350 3789690 4205628 3521762 4435722 FUNDS COLLABORATIVE MEDICAL RESEARCH AND EDUCATION FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES. 0 0 3774197 2525383 THE ORGANIZATION SUPPORTS RESEARCH THROUGH 6 COLLABORATIVE RESEARCH CENTERS AND BY BRINGING TOGETHER A COMMUNITY OF "THOUGHT LEADERS," PATIENTS, CLINICIANS AND RESEARCHERS FOR TARGETED INITIATIVES. OPEN MEDICINE FOUNDATION IS CURRENTLY FOCUSED ON RESEARCHING MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME ("ME/CFS"), AND LONG COVID, IN HOPES OF ALSO REVEALING ANSWERS TO OTHER MULTI SYSTEM CHRONIC COMPLEX DISEASES THAT SHARE SIMILAR SYMPTOMS. ITS 4 PRIMARY GOALS ARE TO: 1).FRAME CLEAR DISEASE MECHANISMS AND MODELS. 2).FIND EFFECTIVE TREATMENT AND DIAGNOSTIC MARKERS. 3). INCREASE ACCURRATE DIAGNOSES. 4). ENSURE ACCESS TO QUALITY CARE. 3774197 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 15 0 1 7 0 0 0 0 0 0 0 0 0 0 0 X 7 5 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA CO CT DC FL GA IL KY MA MD MI MS NC NH NJ NM OH OK OR PA RI SC TN UT VA WA WI WV X X JITASA GROUP 2082874777 1750 W FRONT STREET BOISE ID 83702 LINDA TANNENBAUM CEO/PRESIDENT 40.00 X X 289999 0 18700 KIMBERLY HICKS CFO/TREASURER & COO 40.00 X X 270000 0 18100 DEBORAH ROSE BOARD OF DIRECTORS 5.00 X 0 0 0 HANY ZAYED BOARD OF DIRECTORS 5.00 X 0 0 0 VICKI SHULTZ BOARD OF DIRECTORS 5.00 X 0 0 0 DEBORAH GOULD BOARD OF DIRECTORS 5.00 X 0 0 0 CONNIE MINETT BOARD OF DIRECTORS 5.00 X 0 0 0 JILLIAN PAYNE CHIEF DEVLOPMENT OFFICER 40.00 X 215000 0 16450 DANIELLE MEADOWS VP OF RESEARCH PROGRAMS 40.00 X 166667 0 15724 LINDSAY DAGUERRESSAR DIRECTOR OF DEVELOPMENT 40.00 X 130000 0 13900 1071666 0 82874 5 0 1 0 0 5136428 298581 5136428 230517 230517 OTHER REVENUE 900099 120660 120660 120660 5487605 120660 0 230517 2525383 2525383 560001 338975 67627 153399 808042 482451 99620 225971 92261 52158 12270 27833 81665 46169 10861 24635 273659 208674 46221 18764 94144 47072 47072 65774 19732 13155 32887 7307 7307 44273 42059 2214 138 138 16719 16719 WEBSITE 3002 3002 IN-KIND LABOR 1077 1077 TAXES AND LICENSES 200 200 4573645 3774197 266673 532775 4696190 5665369 1316232 748258 118442 116634 30439 36322 1322 138 0 1184 1123263 2049230 26886 24353 7311452 8641350 69818 102981 3702759 4065663 17113 36984 3789690 4205628 X 1784187 3176379 1737575 1259343 3521762 4435722 7311452 8641350 913960 0 X X 0 1 X 1 0 X 5770635 3985928 5888844 3790096 5136428 24571931 5770635 3985928 5888844 3790096 5136428 24571931 1009826 23562105 39364 -5686 173834 271551 230517 709580 17683 7568 -4053 207937 120660 349795 25631306 0.91930 0.90900 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1322 138 1184 1184 OTHER INVESTMENTS 2049230 F 2049230 X 7110573 1622968 1622968 5487605 0 5487605 5320728 747083 747083 4573645 0 4573645 PART X, LINE 2: UNCERTAIN TAX POSITIONS FOOTNOTE PER AUDITED FINANCIAL STATEMENTS: IN ACCORDANCE WITH ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA, THE ORGANIZATION RECOGNIZES THE IMPACT OF TAX POSITIONS IN THE FINANCIAL STATEMENTS IF THAT POSITION IS MORE LIKELY THAN NOT OF BEING SUSTAINED IN AN AUDIT, BASED ON THE TECHNICAL MERITS OF THE POSITION. TO DATE, THE ORGANIZATION HAD NO TAX POSITIONS WHICH, IN THE OPINION OF MANAGEMENT, WILL BE REVERSED IF CHALLENGED BY A TAXING AUTHORITY. DURING THE YEAR, THE ORGANIZATION DID NOT RECOGNIZE ANY AMOUNT IN POTENTIAL INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS. PART XI, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. PART XII, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. 1 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, GRANTS TO RECIPIENTS GRANTS FUND RESEARCH AND STUDIES FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES 30000 NORTH AMERICA GRANTS TO RECIPIENTS GRANTS FUND RESEARCH AND STUDIES FOR MULTI 1000000 0 0 0 0 0 0 1030000 0 1030000 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, INFLAMMATION STUDY 30000 WIRE TRANSFER 0 NORTH AMERICA RESEARCH 1000000 WIRE TRANSFER 0 0 1 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES REQUESTING RESEARCH FUNDING FROM THE ORGANIZATION MUST DO SO UNDER AN APPROVED GRANT PROPOSAL. ALL GRANT PROPOSALS MUST BE APPROVED FIRST BY THE APPROPRIATE COLLABORATIVE RESEARCH CENTER DIRECTOR, AND THEN BY BOTH THE SCIENTIFIC ADVISORY BOARD EXECUTIVE COMMITTEE AND THE ORGANIZATION'S FULL FOUNDATION BOARD. ONCE THE GRANTS ARE APPROVED, THE ORGANIZATION'S COO/CFO/TREASURER WORKS WITH THE CEO/PRESIDENT, AND KEY CONTACTS AT THE GRANTEE'S INSTITUTION TO CONFIRM AND VALIDATE ALL GRANTEE INFORMATION. ONCE A PAYMENT SCHEDULE IS AGREED BY BOTH THE ORGANIZATION AND GRANTEE A GRANT AGREEMENT IS DISTRIBUTED FOR SIGNATURE ALONG WITH ALL RELEVANT PROJECT DOCUMENTATION. FUNDS ARE THEN DISBURSED ALONG WITH THE COUNTERSIGNED GRANT DOCUMENTATION, AND A LETTER OR EMAIL FROM THE ORGANIZATION CONFIRMING THE INTENDED USE OF THE FUNDS, AND A REQUEST FOR LETTER/EMAIL CONFIRMING RECEIPT OF FUNDS. ALL GRANTEES ARE REQUIRED TO PROVIDE REGULAR UPDATES TO THE ORGANIZATION'S CEO/PRESIDENT ON PROJECT STATUS, AND THE ORGANIZATION'S COO/CFO/TREASURER WORKS WITH KEY CONTACTS AT EACH RECIPIENT INSTITUTION TO RECEIVE FINANCIAL UPDATES. FOR ANY GRANTS REQUIRING PAYMENTS TO THIRD-PARTY RESEARCH LABORATORIES, THE ORGANIZATION'S COO/CFO/TREASURER WILL WORK WITH THE GRANTEE AND THEIR LABORATORY PARTNERS TO ESTABLISH PURCHASE ORDERS WITH APPROVED VENDOR QUOTES, UNDER WHICH FUTURE INVOICE PAYMENTS WILL BE MADE. ALL GRANT AND PURCHASE ORDER PAYMENTS ARE LOGGED AND TRACKED BY THE COO/CFO/TREASURER, AND RECONCILED ON A REGULAR, ONGOING BASIS. 1 BATEMAN HORNE CENTER OF EXCELLENCE 24 SOUTH 1100 EAST SUITE 205 SALT LAKE CITY UT 84102 870687610 100000 0 COMPUTATION & NETWORK MEDICINE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 485 BROADWAY REDWOOD CITY CA 94063 941156365 54605 0 FAMILY OMICS STUDY DAVID SYSTROM 17 GLENGARY ROAD WINCHESTER MA 01890 015481376 20000 0 HARVARD CRC RESEARCH STIPEND JOHANNA WOODWARD SQUIRES 620 ROLLING ROCK ROAD BLOOMFIELD HILLS MI 48304 362197866 24000 0 RESEARCH STIPEND FOR LIFT CLINICAL TRIAL JONAS BERGQUIST 5737 KANAN ROAD AUGORA HILLS CA 91301 264712664 120000 0 MONTHLY STIPEND FOR CHIEF MEDICAL OFFICER PENG LI 19 SHALER LANE APPT 1 CAMBRIDGE MA 02138 646359464 30000 0 COMPUTATION CRC RESEARCH STIPEND SIMARON LLC 800 SOUTHWOOD BLVD 107 INCLINE VILLAGE NV 89451 880403942 120000 0 MECFS RESEARCH SOCIAL AND ENVIRONMENTAL ENTREPRENEURS (SEE) INC 23564 CALABASAS ROAD SUITE 201 CALABASAS CA 91302 954116679 6840 0 PLRC-BALVI GRANT FUNDING FISCAL SPONSOR SUET YING CHRISTIN CHONG 110 ESPLANADE AVENUE APT 217 PACIFICA CA 94044 854215976 12450 0 FUNDRAISING FOR DECENTRALIZED SCIENCE TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER 3601 4TH STREET STOP 6271 LUBBOCK TX 79430 752668014 25818 0 PLRC MOSAICS THE BRIGHAM AND WOMEN'S HOSPITAL INC 38 SIDNEY STREET SUITE 161 CAMBRIDGE MA 02139 042312909 300000 0 POST EXTERTIONAL MALAISE MUSCLE BIOPSY STUDY & LIFT TRIAL THE GENERAL HOSPITAL CORPORATION 37 SIDNEY STREET SUITE 161 CAMBRIDGE MA 02139 042697983 500000 0 COMPUTATION & NETWORK MEDICINE WENZHONG XIAO 40460 SEVILLE CT FREMONT CA 94539 620740492 90000 0 RESEARCH STIPENDS FOR CHIEF MEDICAL OFFICER AND COMPUTATION DIRECTOR 0 11 X X 0 0 0 0 0 0 0 0 0 LINDA TANNENBAUM CEO/PRESIDENT 289999 0 0 0 0 0 8700 0 10000 0 308699 0 0 0 KIMBERLY HICKS CFO/TREASURER & COO 270000 0 0 0 0 0 8100 0 10000 0 288100 0 0 0 JILLIAN PAYNE CHIEF DEVLOPMENT OFFICER 215000 0 0 0 0 0 6450 0 10000 0 231450 0 0 0 DANIELLE MEADOWS VP OF RESEARCH PROGRAMS 166667 0 0 0 0 0 5724 0 10000 0 182391 0 0 0 OPEN MEDICINE FOUNDATION AUSTRALIA RELATED ORGANIZATION OPERATIONAL SUPPORT X 7853 0 1 1 OPEN MEDICINE FOUNDATION CANADA RELATED ORGANIZATION OPERATIONAL SUPPORT X 108781 0 1 1 OPEN MEDICINE FOUNDATION AUSTRALIA RELATED ORGANIZATION SALARY REIMBURSEMENT X 36984 0 1 1 153618 X 5 298581 0 1 0 FORM 990, PART VI, SECTION B, LINE 11B THE COO/CFO/TREASURER OBTAINS THE FINAL DRAFT OF THE FORM 990 FROM THE ORGANIZATON'S THIRD-PARTY 990 PREPARER AND REVIEWS. THE COO/CFO/TREASURER THEN DISTRIBUTES THE COPIES OF THE FORM 990 FINAL DRAFT TO THE BOARD. THE BOARD WILL REVIEW AND APPROVE THE FINAL FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY, DURING BOD ELECTIONS, MEMBERS ARE ASKED TO SIGN THE CONFLICT OF INTEREST POLICY CONFIRMING THAT THEY UNDERSTAND THE POLICY AND ARE IN CONFORMITY WITH THE POLICY. ALL NEW STAFF AND BOARD MEMBERS ARE INFORMED OF THE POLICY AND ASKED IF THEY HAVE ANY CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ALL CHANGES IN MANAGEMENT COMPENSATION AND HIRING ARE APPROVED BY A VOTE OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THERE HAVE BEEN NO CHANGES IN OVERSIGHT OR THE SELECTION PROCESS DURING THE YEAR.